These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36206192)

  • 1. MAP kinase activating death domain deficiency is a novel cause of impaired lymphocyte cytotoxicity.
    Schütze K; Groß M; Cornils K; Wustrau K; Schneppenheim S; Lenhartz H; Korenke GC; Janka G; Ledig S; Müller I; Ehl S; Lehmberg K
    Blood Adv; 2023 Apr; 7(8):1531-1535. PubMed ID: 36206192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MADD regulates natural killer cell degranulation through Rab27a activation.
    Medlyn MJ; Maeder E; Bradley C; Phatarpekar P; Ham H; Billadeau DD
    J Cell Sci; 2024 Apr; 137(7):. PubMed ID: 38506245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different NK cell-activating receptors preferentially recruit Rab27a or Munc13-4 to perforin-containing granules for cytotoxicity.
    Wood SM; Meeths M; Chiang SC; Bechensteen AG; Boelens JJ; Heilmann C; Horiuchi H; Rosthøj S; Rutynowska O; Winiarski J; Stow JL; Nordenskjöld M; Henter JI; Ljunggren HG; Bryceson YT
    Blood; 2009 Nov; 114(19):4117-27. PubMed ID: 19704116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of hemophagocytic lymphohistiocytosis in Hermansky-Pudlak syndrome type 2.
    Jessen B; Bode SF; Ammann S; Chakravorty S; Davies G; Diestelhorst J; Frei-Jones M; Gahl WA; Gochuico BR; Griese M; Griffiths G; Janka G; Klein C; Kögl T; Kurnik K; Lehmberg K; Maul-Pavicic A; Mumford AD; Pace D; Parvaneh N; Rezaei N; de Saint Basile G; Schmitt-Graeff A; Schwarz K; Karasu GT; Zieger B; Zur Stadt U; Aichele P; Ehl S
    Blood; 2013 Apr; 121(15):2943-51. PubMed ID: 23403622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemophagocytic lymphohistiocytosis in syntaxin-11-deficient mice: T-cell exhaustion limits fatal disease.
    Kögl T; Müller J; Jessen B; Schmitt-Graeff A; Janka G; Ehl S; zur Stadt U; Aichele P
    Blood; 2013 Jan; 121(4):604-13. PubMed ID: 23190531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases.
    Rohr J; Beutel K; Maul-Pavicic A; Vraetz T; Thiel J; Warnatz K; Bondzio I; Gross-Wieltsch U; Schündeln M; Schütz B; Woessmann W; Groll AH; Strahm B; Pagel J; Speckmann C; Janka G; Griffiths G; Schwarz K; zur Stadt U; Ehl S
    Haematologica; 2010 Dec; 95(12):2080-7. PubMed ID: 20823128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NBAS, a gene involved in cytotoxic degranulation, is recurrently mutated in pediatric hemophagocytic lymphohistiocytosis.
    Bi X; Zhang Q; Chen L; Liu D; Li Y; Zhao X; Zhang Y; Zhang L; Liu J; Wu C; Li Z; Zhao Y; Ma H; Huang G; Liu X; Wang QF; Zhang R
    J Hematol Oncol; 2022 Jul; 15(1):101. PubMed ID: 35902954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical presentation of Griscelli syndrome type 2 and spectrum of RAB27A mutations.
    Meeths M; Bryceson YT; Rudd E; Zheng C; Wood SM; Ramme K; Beutel K; Hasle H; Heilmann C; Hultenby K; Ljunggren HG; Fadeel B; Nordenskjöld M; Henter JI
    Pediatr Blood Cancer; 2010 Apr; 54(4):563-72. PubMed ID: 19953648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening for cytotoxic defects with flow cytometric detection of CD107α on natural killer cells and cytotoxic lymphocyte cells].
    Wang J; Liu Z; Jiang LP; An YF; Zhao XD
    Zhonghua Er Ke Za Zhi; 2012 May; 50(5):386-91. PubMed ID: 22883044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GDP/GTP exchange factor MADD drives activation and recruitment of secretory Rab GTPases to Weibel-Palade bodies.
    Kat M; Bürgisser PE; Janssen H; De Cuyper IM; Conte IL; Hume AN; Carter T; Voorberg J; Margadant C; Bierings R
    Blood Adv; 2021 Dec; 5(23):5116-5127. PubMed ID: 34551092
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Benavides N; Spessott WA; Sanmillan ML; Vargas M; Livingston MS; Erickson N; Pozos TC; McCormick ME; Scharrig E; Messinger YH; Giraudo CG
    Front Immunol; 2020; 11():545414. PubMed ID: 33162974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polygenic mutations in the cytotoxicity pathway increase susceptibility to develop HLH immunopathology in mice.
    Sepulveda FE; Garrigue A; Maschalidi S; Garfa-Traore M; Ménasché G; Fischer A; de Saint Basile G
    Blood; 2016 Apr; 127(17):2113-21. PubMed ID: 26864340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell transplantation in children with Griscelli Syndrome type 2: Experience and outcomes.
    Gupta D; Thakral D; Bakhshi S; Kabra SK; Mitra DK
    Indian J Pathol Microbiol; 2019; 62(2):279-282. PubMed ID: 30971555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A CD57
    Hori M; Yasumi T; Shimodera S; Shibata H; Hiejima E; Oda H; Izawa K; Kawai T; Ishimura M; Nakano N; Shirakawa R; Nishikomori R; Takada H; Morita S; Horiuchi H; Ohara O; Ishii E; Heike T
    J Clin Immunol; 2017 Jan; 37(1):92-99. PubMed ID: 27896523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective granule exocytosis in Rab27a-deficient lymphocytes from Ashen mice.
    Haddad EK; Wu X; Hammer JA; Henkart PA
    J Cell Biol; 2001 Feb; 152(4):835-42. PubMed ID: 11266473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cytotoxicity mediated by CD16 but not by NKp30 is functional in Griscelli syndrome.
    Gazit R; Aker M; Elboim M; Achdout H; Katz G; Wolf DG; Katzav S; Mandelboim O
    Blood; 2007 May; 109(10):4306-12. PubMed ID: 17255357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digenic Inheritance: Evidence and Gaps in Hemophagocytic Lymphohistiocytosis.
    Steen EA; Hermiston ML; Nichols KE; Meyer LK
    Front Immunol; 2021; 12():777851. PubMed ID: 34868048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perforin and CD107a testing is superior to NK cell function testing for screening patients for genetic HLH.
    Rubin TS; Zhang K; Gifford C; Lane A; Choo S; Bleesing JJ; Marsh RA
    Blood; 2017 Jun; 129(22):2993-2999. PubMed ID: 28270454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Natural killer cell cytotoxic activity in critical pediatric patients with suspected hemophagocytic syndrome].
    Martínez I; Fernández L; Valentín J; Castillo C; Chamorro C; Pérez-Martínez A
    Med Intensiva; 2015 May; 39(4):213-21. PubMed ID: 25081072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes.
    Bryceson YT; Pende D; Maul-Pavicic A; Gilmour KC; Ufheil H; Vraetz T; Chiang SC; Marcenaro S; Meazza R; Bondzio I; Walshe D; Janka G; Lehmberg K; Beutel K; zur Stadt U; Binder N; Arico M; Moretta L; Henter JI; Ehl S
    Blood; 2012 Mar; 119(12):2754-63. PubMed ID: 22294731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.